Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Clinical trial NCT05027776 · RECRUITING

Trial details

NCT number: NCT05027776
Sponsor: Shanghai Bovax Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HPV Infections Cervical Cancer Stage IIa Vaginal Cancer Genital Wart CIN1 CIN2 CIN3

Start date: 2021-09-15
Primary completion: 2023-11-22
Enrollment: 1348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.